How to buy IDEXX Laboratories stock (IDXX)

IDEXX Laboratories is a diagnostics & research business based in the US. IDEXX Laboratories shares (IDXX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $410.76 – a decrease of 6.04% over the previous week. IDEXX Laboratories employs 11,000 staff and has a trailing 12-month revenue of around $3.8 billion.

Our top picks for where to buy IDEXX Laboratories stock

Buy IDEXX Laboratories stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

IDEXX Laboratories stock price (NASDAQ: IDXX)

Use our graph to track the performance of IDXX stocks over time.

IDEXX Laboratories shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$410.76
52-week range	$398.50 - $583.39
50-day moving average more info button	$438.80
200-day moving average more info button	$484.06
Wall St. target price	$478.62
PE ratio more info button	39.687
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$10.35

Is it a good time to buy IDEXX Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IDEXX Laboratories price performance over time

Historical closes compared with the close of $427.09 from 2024-12-17

1 week (2024-12-12)	-2.31%
1 month (2024-11-20)	2.03%
3 months (2024-09-19)	-17.40%
6 months (2024-06-18)	-15.19%

1 year (2023-12-19)	-21.74%
2 years (2022-12-19)	6.20%
3 years (2021-12-17)	616.88
5 years (2019-12-19)	66.71%

Is IDEXX Laboratories stock undervalued or overvalued?

Valuing IDEXX Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IDEXX Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

IDEXX Laboratories's P/E ratio

IDEXX Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, IDEXX Laboratories shares trade at around 40x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

IDEXX Laboratories's PEG ratio

IDEXX Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.4955. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IDEXX Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

IDEXX Laboratories's EBITDA

IDEXX Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.

The EBITDA is a measure of a IDEXX Laboratories's overall financial performance and is widely used to measure a its profitability.

IDEXX Laboratories financials

Revenue TTM	$3.8 billion
Operating margin TTM	37.46%
Gross profit TTM	$2 billion
Return on assets TTM	22.79%
Return on equity TTM	59.42%
Profit margin	22.53%
Book value	$19.72
Market Capitalization more info button	$33.6 billion

TTM: trailing 12 months

IDEXX Laboratories's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like IDEXX Laboratories.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

IDEXX Laboratories's total ESG risk score

Total ESG risk: 29.79

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and IDEXX Laboratories's overall score of 29.79 (as at 12/31/2018) is nothing to write home about – landing it in it in the 55th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like IDEXX Laboratories is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

IDEXX Laboratories's environmental score

Environmental score: 9.93/100

IDEXX Laboratories's environmental score of 9.93 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that IDEXX Laboratories is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

IDEXX Laboratories's social score

Social score: 14.44/100

IDEXX Laboratories's social score of 14.44 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that IDEXX Laboratories is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

IDEXX Laboratories's governance score

Governance score: 17.91/100

IDEXX Laboratories's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that IDEXX Laboratories is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Environmental, social, and governance (ESG) summary

IDEXX Laboratories Inc was last rated for ESG on: 2019-01-01.

Total ESG score	29.79
Total ESG percentile	54.84
Environmental score	9.93
Environmental score percentile	6
Social score	14.44
Social score percentile	6
Governance score	17.91
Governance score percentile	6

IDEXX Laboratories share dividends

We're not expecting IDEXX Laboratories to pay a dividend over the next 12 months.

Have IDEXX Laboratories's shares ever split?

IDEXX Laboratories's shares were split on a 2:1 basis on 15 June 2015 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your IDEXX Laboratories shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for IDEXX Laboratories shares which in turn could have impacted IDEXX Laboratories's share price.

IDEXX Laboratories share price volatility

Over the last 12 months, IDEXX Laboratories's shares have ranged in value from as little as $398.5 up to $583.39. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IDEXX Laboratories's is 1.357. This would suggest that IDEXX Laboratories's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

IDEXX Laboratories overview

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups.

Frequently asked questions

null
What percentage of IDEXX Laboratories is owned by insiders or institutions?
Currently 0.942% of IDEXX Laboratories shares are held by insiders and 94.342% by institutions. How many people work for IDEXX Laboratories?
Latest data suggests 11,000 work at IDEXX Laboratories. When does the fiscal year end for IDEXX Laboratories?
IDEXX Laboratories's fiscal year ends in December. Where is IDEXX Laboratories based?
IDEXX Laboratories's address is: One IDEXX Drive, Westbrook, ME, United States, 04092 What is IDEXX Laboratories's ISIN number?
IDEXX Laboratories's international securities identification number is: US45168D1046 What is IDEXX Laboratories's CUSIP number?
IDEXX Laboratories's Committee on Uniform Securities Identification Procedures number is: 45168D104